Corpus Intelligence IC Memo — SALEM MEMORIAL DISTRICT HOSPITAL 2026-04-26 15:56 UTC
IC Memo — SALEM MEMORIAL DISTRICT HOSPITAL
Investment Committee Memorandum | MO | 25 beds | Grade C | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SALEM MEMORIAL DISTRICT HOSPITAL

CCN 261318 | DENT, MO | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SALEM MEMORIAL DISTRICT HOSPITAL is a 25-bed rural/critical access in DENT, MO with $26.2M in net patient revenue and a -18.7% operating margin. The hospital serves a payer mix of 64.2% Medicare, 6.3% Medicaid, and 29.5% commercial.

Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -18.7% to -11.3% (+736bps).

Net Revenue HCRIS$26.2M
Current EBITDA COMPUTED$-4.9M
Operating Margin COMPUTED-18.7%
Occupancy HCRIS35.9%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS40.6%
Distress Probability ML54.7%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
61
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -18.7% places it below the state median. Among 61 size-comparable peers (12-50 beds), the median margin is -9.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 61 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SALEM MEMORIAL DISTRICT HOSPIT (Target)MO25$26.2M-18.7%
GOLDEN VALLEY MEMORIAL HOSPITAMO42$139.8M-4.9%
WESTERN MISSOURI MEDICAL CENTEMO45$108.5M-9.2%
MERCY HOSPITAL LEBANONMO43$94.1M15.5%
CASS REGIONAL MEDICAL CENTERMO25$89.9M5.4%
MISSOURI BAPTIST SULLIVAN HOSPMO25$73.4M2.7%
MOSAIC MEDICAL CENTER - MARYVIMO29$73.3M-40.5%
NORTHEAST REGIONAL MEDICAL CENMO40$70.6M43.6%
FULTON STATE HOSPITALMO49$68.9M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$550K+210bp18mo
Cost to Collect4.5%2.5%$524K+200bp12mo
Denial Rate Reduction12.0%6.5%$519K+198bp12mo
A/R Days Reduction5200.0%3800.0%$319K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$550K
Cost to Collect
$524K
Denial Rate Reduction
$519K
A/R Days Reduction
$319K
Clean Claim Rate
$17K
Total EBITDA Uplift$1.9M
Current EBITDA$-4.9M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$-3.0M
Current Margin-18.7%
Pro Forma Margin-11.3%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.5M$-13.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.5M$-16.7M0.00x-100.0%
Bull Case9.0x11.0x$-6.8M$-12.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.8M$-16.0M0.00x-100.0%
Bear Case11.0x10.0x$-8.3M$-20.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.3M$-24.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 64.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 54.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 61 hospitals with 12-50 beds
  • Same-state prioritization (n=62)
  • Comp margins: P25=-17.4% / P50=-9.6% / P75=-0.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.